Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells

Clinical Immunology

Volumn 107, Issue 3, 2003, Pages 198-201

  Miyazaki, Mikinori ^a,b   Akatsuka, Yoshiki ^a   Nishida, Tetsuya ^a,c   Fujii, Nobuharu ^d   Hiraki, Akio ^d   Ikeda, Kazuma ^d   Tsujimura, Kunio ^a   Kuzushima, Kiyotaka ^a   Morishima, Yasuo ^a   Sato, Shigeki ^b   Ueda, Ryuzo ^b   Takahashi, Toshitada ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytotoxic T lymphocyte; HA 1; Minor histocompatibility antigen; Solid tumor; Transporter associated with antigen processing

Indexed keywords

CHROMIUM 51; GAMMA INTERFERON; ISOPROTEIN; MINOR HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GENETIC CODE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOLID TUMOR; TUMOR CELL LINE; TUMOR IMMUNITY;

EID: 0038541695     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00065-2     Document Type: Article

References (11)

1. Eibl B., Schwaighofer H., Nachbaur D., et al. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood. 88:1996;1501-1508.
2. Childs R.W., Clave E., Tisdale J., Plante M., Hensel N., Barrett J. Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant evidence for a graft-versus-tumor effect . J. Clin. Oncol. 17:1999;2044-2049.
3. Goulmy E. Human minor histocompatibility antigens. Curr. Opin. Immunol. 8:1996;75-81.
4. den Haan J.M., Meadows L.M., Wang W., et al. The minor histocompatibility antigen HA-1 a diallelic gene with a single amino acid polymorphism . Science. 279:1998;1054-1057.
5. Fujii N., Hiraki A., Ikeda K., et al. Expression of minor histocompatibility antigen, HA-1, in solid tumor cells. Transplantation. 73:2002;1137-1141.
6. Klein C.A., Wilke M., Pool J., et al. The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. J. Exp. Med. 196:2002;359-368.
7. Akatsuka Y., Goldberg T.A., Kondo E., et al. Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens. 59:2002;502-511.
8. Kondo E., Topp M.S., Kiem H., et al. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. J. Immunol. 169:2002;2164-2171.
9. Restifo N., Esquivel F., Kawakami Y., et al. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:1993;265-272.
10. Natali P.G., Nicotra M.R., Bigotti A., et al. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc. Natl. Acad. Sci. USA. 86:1989;6719-6723.
11. Ferrara J.L. Cytokine dysregulation as a mechanism of graft versus host disease. Curr. Opin. Immunol. 5:1993;794-799.